SCHEMBL534893

SCHEMBL534893

c1ccc2cc(-c3ncc[nH]3)ccc2c1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NISCH Q9Y2I1 3/20 0.60
MTOR P42345 1/20 0.60
ADK P55263 1/20 0.60
ADRA2A P08913 2/20 0.50
CYP1A2 P05177 3/20 0.46
CYP19A1 P11511 2/20 0.46
CYP2C9 P11712 2/20 0.46
CYP2C19 P33261 2/20 0.46
CYP3A4 P08684 1/20 0.46
CYP2D6 P10635 1/20 0.46
ALDH1A1 P00352 4/20 0.46
KDM4E B2RXH2 3/20 0.46
CYP11B1 P15538 2/20 0.46
CYP11B2 P19099 2/20 0.46
CYP17A1 P05093 1/20 0.44
ADRA2B P18089 1/20 0.44
ADRA2C P18825 1/20 0.44
MAPK8 P45983 1/20 0.44
MAPK9 P45984 1/20 0.44
MAPK10 P53779 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29613953 1.00 NISCH (0.60) NISCHMTORADKADRA2ACYP1A2
SCHEMBL27825170 0.95 NISCH (0.58) NISCHMTORADKADRA2ACYP1A2
SCHEMBL16246674 0.93 NISCH (0.61) NISCHMTORADKADRA2ACYP1A2
SCHEMBL26260184 0.92 NISCH (0.59) NISCHMTORADKADRA2ACYP1A2
SCHEMBL26260204 0.90 NISCH (0.57) NISCHMTORADKADRA2ACYP1A2
SCHEMBL5914833 0.87 NISCH (0.50) NISCHMTORADKADRA2ACYP1A2
SCHEMBL27843956 0.86 NISCH (0.53) NISCHMTORADKADRA2ACYP1A2
SCHEMBL5914819 0.86 NISCH (0.53) NISCHMTORADKADRA2ACYP1A2
SCHEMBL5914816 0.85 NISCH (0.51) NISCHMTORADKADRA2ACYP1A2
SCHEMBL2652034 0.81 NPC1 (0.65) NISCHMTORADKADRA2ACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110483504-B Novel method for constructing 2- (2-naphthyl) imidazole [1,2-a ] pyridine-3-aldehyde by using DMF (dimethyl formamide) as formylation reagent 桂林理工大学 2022-04-26 CN claimed
CN-105087182-A Circuit substrate cured with solder, a manufacturing method of circuit substrate equipped with electronic part, and cleaning agent composition for fluxing agent KAO CORP 2015-11-25 CN claimed
US-20240118612-A1 PHOTOSENSITIVE RESIN COMPOSITION, METHOD FOR MANUFACTURING RESIST PATTERN FILM, AND METHOD FOR MANUFACTURING PLATED SHAPED ARTICLE JSR CORPORATION (JP) 2024-04-11 US disclosed
CN-111258180-B Hexaarylbisimidazoles mixed photoinitiator and application thereof 常州正洁智造科技有限公司 2024-03-08 CN disclosed
US-20230287262-A1 PHOTON UPCONVERSION COMPOSITION, FILM, METHOD FOR CONVERTING VISIBLE LIGHT INTO ULTRAVIOLET LIGHT, AND COMPOUND KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION (JP) 2023-09-14 US disclosed
US-20230287262-A1 PHOTON UPCONVERSION COMPOSITION, FILM, METHOD FOR CONVERTING VISIBLE LIGHT INTO ULTRAVIOLET LIGHT, AND COMPOUND KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION (JP) 2023-09-14 US disclosed
CN-114644860-A Pigment dispersion composition for black matrix, resist composition for black matrix, and black matrix 阪田油墨株式会社 2022-06-21 CN disclosed
CN-110483504-B Novel method for constructing 2- (2-naphthyl) imidazole [1,2-a ] pyridine-3-aldehyde by using DMF (dimethyl formamide) as formylation reagent 桂林理工大学 2022-04-26 CN disclosed
CN-110483504-B Novel method for constructing 2- (2-naphthyl) imidazole [1,2-a ] pyridine-3-aldehyde by using DMF (dimethyl formamide) as formylation reagent 桂林理工大学 2022-04-26 CN disclosed
CN-110483504-B Novel method for constructing 2- (2-naphthyl) imidazole [1,2-a ] pyridine-3-aldehyde by using DMF (dimethyl formamide) as formylation reagent 桂林理工大学 2022-04-26 CN disclosed
WO-2021080021-A1 METHOD FOR PRODUCING OLIGONUCLEOTIDE 日東電工株式会社 2021-04-29 WO disclosed
WO-2010068287-A2 SMALL MOLECULE MODULATORS OF HEPATOCYTE GROWTH FACTOR (SCATTER FACTOR) ACTIVITY ANGION BIOMEDICA CORP. (US) 2010-06-17 WO disclosed
US-20090258202-A1 Method for Producing Metal Particle Dispersion, Conductive Ink Using Metal Particle Dispersion Produced by Such Method, and Conductive Coating Film GVP GESELLSCHAFT ZUR VERMARKTUNG DER PORENBRENNERTECHNIK MBH (DE) 2009-10-15 US disclosed
CN-101384674-A Colored metallic pigment, process for producing the same, and coating composition and cosmetic preparation comprising said colored metallic pigment TOYO ALUMINIUM KK (JP) 2009-03-11 CN disclosed
US-20090017082-A1 COLORED METALLIC PIGMENT, PROCESS FOR PRODUCING THE SAME, AND COATING COMPOSITION AND COSMETIC PREPARATION CONTAINING SAID COLORED METALLIC PIGMENT TOYO ALUMINIUM KABUSHIKI KAISHA (JP) 2009-01-15 US disclosed
EP-1990377-A1 COLORED METALLIC PIGMENT, PROCESS FOR PRODUCING THE SAME, AND COATING COMPOSITION AND COSMETIC PREPARATION COMPRISING SAID COLORED METALLIC PIGMENT TOYO ALUMINIUM KABUSHIKI KAISHA (JP) 2008-11-12 EP disclosed
CN-101287566-A Method for producing metal microparticle dispersion, conductive ink using metal microparticle dispersion produced by the method, and conductive coating film TOYO INK MFG CO (JP) 2008-10-15 CN disclosed
EP-1952918-A1 METHOD FOR PRODUCING METAL PARTICLE DISPERSION, CONDUCTIVE INK USING METAL PARTICLE DISPERSION PRODUCED BY SUCH METHOD, AND CONDUCTIVE COATING FILM Toyo Ink Mfg. Co., Ltd (JP) 2008-08-06 EP disclosed
US-7388100-B2 Tertiary amine compounds NISHIO TETSUYA 2008-06-17 US disclosed
US-20060145145-A1 Tertiary amine compounds, organic semiconductor devices using the same and organic electroluminescence devices using the same NISHIO TETSUYA 2006-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060145145-A1 Tertiary amine compounds, organic semiconductor devices using the same and organic electroluminescence devices using the same PIEZO1, YES1, SAT1 NISCH 884/4885MTOR 355/4885ADK 871/4885
US-20230287262-A1 PHOTON UPCONVERSION COMPOSITION, FILM, METHOD FOR CONVERTING VISIBLE LIGHT INTO ULTRAVIOLET LIGHT, AND COMPOUND NUDC, CCNL2, SPIN3 NISCH 172/4885MTOR 1582/4885ADK 3847/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.